Doemer Anthony, Chetty Indrin J, Glide-Hurst Carri, Nurushev Teamour, Hearshen David, Pantelic Milan, Traughber Melanie, Kim Joshua, Levin Kenneth, Elshaikh Mohamed A, Walker Eleanor, Movsas Benjamin
Department of Radiation Oncology, Henry Ford Health System, 2799 W. Grand Blvd, Detroit, MI, 48202, USA.
Department of Radiation Oncology, 21st Century Oncology, 28585 Orchard Lake Rd, Suite 110, Farmington Hills, MI, 48334, USA.
Radiat Oncol. 2015 Feb 11;10:37. doi: 10.1186/s13014-014-0309-0.
This study describes initial testing and evaluation of a vertical-field open Magnetic Resonance Imaging (MRI) scanner for the purpose of simulation in radiation therapy for prostate cancer. We have evaluated the clinical workflow of using open MRI as a sole modality for simulation and planning. Relevant results related to MRI alignment (vs. CT) reference dataset with Cone-Beam CT (CBCT) for daily localization are presented.
Ten patients participated in an IRB approved study utilizing MRI along with CT simulation with the intent of evaluating the MRI-simulation process. Differences in prostate gland volume, seminal vesicles, and penile bulb were assessed with MRI and compared to CT. To evaluate dose calculation accuracy, bulk-density-assignments were mapped onto respective MRI datasets and treated IMRT plans were re-calculated. For image localization purposes, 400 CBCTs were re-evaluated with MRI as the reference dataset and daily shifts compared against CBCT-to-CT registration. Planning margins based on MRI/CBCT shifts were computed using the van Herk formalism.
Significant organ contour differences were noted between MRI and CT. Prostate volumes were on average 39.7% (p = 0.002) larger on CT than MRI. No significant difference was found in seminal vesicle volumes (p = 0.454). Penile bulb volumes were 61.1% higher on CT, without statistical significance (p = 0.074). MRI-based dose calculations with assigned bulk densities produced agreement within 1% with heterogeneity corrected CT calculations. The differences in shift positions for the cohort between CBCT-to-CT registration and CBCT-to-MRI registration are -0.15 ± 0.25 cm (anterior-posterior), 0.05 ± 0.19 cm (superior-inferior), and -0.01 ± 0.14 cm (left-right).
This study confirms the potential of using an open-field MRI scanner as primary imaging modality for prostate cancer treatment planning simulation, dose calculations and daily image localization.
本研究描述了一种垂直场开放式磁共振成像(MRI)扫描仪的初步测试和评估,目的是用于前列腺癌放射治疗的模拟。我们评估了将开放式MRI作为唯一模拟和规划方式的临床工作流程。给出了与用于每日定位的锥形束CT(CBCT)的MRI对齐(与CT相比)参考数据集相关的结果。
10名患者参与了一项经机构审查委员会批准的研究,该研究利用MRI以及CT模拟来评估MRI模拟过程。通过MRI评估前列腺体积、精囊和阴茎球部的差异,并与CT进行比较。为了评估剂量计算准确性,将体密度赋值映射到各自的MRI数据集上,并重新计算治疗的调强放疗(IMRT)计划。为了进行图像定位,以MRI作为参考数据集对400次CBCT进行重新评估,并将每日移位与CBCT到CT的配准进行比较。使用范赫克公式计算基于MRI/CBCT移位的计划边界。
MRI和CT之间存在明显的器官轮廓差异。前列腺体积在CT上平均比MRI大39.7%(p = 0.002)。精囊体积未发现显著差异(p = 0.454)。阴茎球部体积在CT上高61.1%,无统计学意义(p = 0.074)。基于MRI并指定体密度的剂量计算与经不均匀性校正的CT计算结果在1%以内相符。该队列在CBCT到CT配准和CBCT到MRI配准之间的移位位置差异为-0.15±0.25厘米(前后)、0.05±0.19厘米(上下)和-0.01±0.14厘米(左右)。
本研究证实了使用开放式MRI扫描仪作为前列腺癌治疗计划模拟、剂量计算和每日图像定位的主要成像方式的潜力。